SMN1 and proximal spinal muscular atrophy: The permanent and precise editing of endogenous SMN2 genes that preserves native transcript levels and native regulatory mechanisms governing SMN expression thus may address shortcomings of existing SMA therapies(1, 4, 5, 21, 28, 78).